{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=lorazepam", "query": { "intervention": "lorazepam" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 100, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=lorazepam&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T10:21:06.897Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03743649", "title": "Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Delirium", "Locally Advanced Malignant Neoplasm", "Metastatic Malignant Neoplasm", "Recurrent Malignant Neoplasm" ], "interventions": [ { "name": "Haloperidol", "type": "DRUG" }, { "name": "Lorazepam", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 110, "start_date": "2019-07-17", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-06-15", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 2, "location_summary": "Houston, Texas • Richmond, Virginia", "locations": [ { "city": "Houston", "state": "Texas" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03743649" }, { "nct_id": "NCT02096575", "title": "Nitrous Oxide for Pain Management of First Trimester Surgical Abortion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Abortion in First Trimester" ], "interventions": [ { "name": "Nitrous oxide administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 140, "start_date": "2012-08", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2016-04-19", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02096575" }, { "nct_id": "NCT00736931", "title": "Clinical Study in Healthy Volunteers to Investigate the Neurocognitive Effects of a New Antiepileptic Drug: Brivaracetam", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Brivaracetam", "type": "DRUG" }, { "name": "levetiracetam", "type": "DRUG" }, { "name": "lorazepam", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "UCB Pharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 20, "start_date": "2008-07", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2012-05-28", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00736931" }, { "nct_id": "NCT00641797", "title": "Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Benign Paroxysmal Positional Vertigo" ], "interventions": [ { "name": "Meclizine", "type": "DRUG" }, { "name": "Epley Maneuver", "type": "OTHER" }, { "name": "Lorazepam", "type": "DRUG" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Ondansetron", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Lehigh Valley Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 26, "start_date": "2006-11", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2018-04-03", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "Allentown, Pennsylvania", "locations": [ { "city": "Allentown", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00641797" }, { "nct_id": "NCT01011634", "title": "Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Undesired Intrauterine Pregnancy", "First Trimester Pregnancy" ], "interventions": [ { "name": "Intravenous moderate sedation versus oral medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "55 Years", "sex": "FEMALE", "summary": "16 Years to 55 Years · Female only" }, "enrollment_count": 18, "start_date": "2007-05", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2013-05-16", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01011634" }, { "nct_id": "NCT00809146", "title": "Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Status Epilepticus" ], "interventions": [ { "name": "Intramuscular route of active treatment", "type": "DRUG" }, { "name": "Intravenous route of active treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Robert Silbergleit", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1023, "start_date": "2009-06", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2016-06-17", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 17, "location_summary": "Tucson, Arizona • Palo Alto, California • San Francisco, California + 12 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00809146" }, { "nct_id": "NCT00807937", "title": "Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Anxiety Disorders" ], "interventions": [ { "name": "AZD7325", "type": "DRUG" }, { "name": "Lorazepam", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 369, "start_date": "2008-12", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2010-10-08", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 51, "location_summary": "Mesa, Arizona • Little Rock, Arkansas • Carson, California + 48 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carson", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00807937" }, { "nct_id": "NCT05662228", "title": "Therapies for Down Syndrome Regression Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Down Syndrome", "Regression" ], "interventions": [ { "name": "Lorazepam", "type": "DRUG" }, { "name": "Intravenous immunoglobulin (IVIG)", "type": "DRUG" }, { "name": "Tofacitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "8 Years to 30 Years" }, "enrollment_count": 66, "start_date": "2023-06-29", "completion_date": "2026-05-28", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 2, "location_summary": "Los Angeles, California • Aurora, Colorado", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05662228" }, { "nct_id": "NCT01505569", "title": "Auto Transplant for High Risk or Relapsed Solid or CNS Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Ewing's Family Tumors", "Renal Tumors", "Hepatoblastoma", "Rhabdomyosarcoma", "Soft Tissue Sarcoma", "Primary Malignant Brain Neoplasms", "Retinoblastoma", "Medulloblastoma", "Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET)", "Atypical Teratoid/Rhabdoid Tumor (AT/RT)", "CNS Tumors", "Germ Cell Tumors" ], "interventions": [ { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" }, { "name": "G-CSF", "type": "BIOLOGICAL" }, { "name": "Busulfan", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" }, { "name": "Autologous stem cell infusion", "type": "BIOLOGICAL" }, { "name": "Radiation", "type": "RADIATION" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "Anti-seizure prophylaxis", "type": "DRUG" }, { "name": "Ursodiol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "RADIATION", "PROCEDURE" ], "sponsor": "Masonic Cancer Center, University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "ALL", "summary": "Up to 70 Years" }, "enrollment_count": 44, "start_date": "2011-10-20", "completion_date": "2024-02-01", "has_results": false, "last_update_posted_date": "2024-02-26", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01505569" }, { "nct_id": "NCT07560878", "title": "Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Major Depression" ], "interventions": [ { "name": "D-Cycloserine (DCS)", "type": "DRUG" }, { "name": "Continuous theta-burst stimulation (cTBS)", "type": "DEVICE" }, { "name": "Transcranial Magnetic Stimulation Sham", "type": "DEVICE" }, { "name": "Memantine", "type": "DRUG" }, { "name": "Lorazepam (drug)", "type": "DRUG" }, { "name": "Baclofen", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Mclean Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2026-03-11", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-09-03T10:21:06.897Z", "location_count": 1, "location_summary": "Belmont, Massachusetts", "locations": [ { "city": "Belmont", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07560878" } ] }